Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Digital Health & Informatics
Diversity, Equity and Inclusion
Health & Wellness
Opioids & Pain Management
Sterile Compounding
89 Views
Favorite
0
Like
Facebook
Tweet
Print
Email
Resident Poster
(10-148) Cost-Benefit Analysis of Using Premix versus Compounded Oxytocin, Dexmedetomidine, and Bupivacaine and Fentanyl Epidural Continuous IV Infusions
Wednesday, December 11, 2024
11:00 AM – 12:00 PM
Location: Hall G, Lower Level
Category:
Research-in-Progress
Topic:
Administrative Practice/Management/Financial Management/Human Resources
Co-Author(s):
Jacob DeSalvo, Shirley Felder, Alexis Kasniunas
Primary Author(s)
Margi Sheth, PharmD